Statistics for Repro-Med Systems (id:5492 KRMD)

Valuation metrics

Market cap

144.44M

Enterprise value

134.74M

Trailing P/E (ttm)

-12.17

Forward P/E

-35.00

PEG ratio

-35.00

Price/Sales (ttm)

4.69

Price/Book (mrq)

7.06

Enterprise Value/Revenue

4.37

Enterprise Value/EBITDA

-21.56

Overview

Shares outstanding

45.86M

Float

33.47M

Shares short

486.92K

% Held by insiders

0.06%

% Held by institutions

0.54%

Average volume (10 days)

58.56K

Average volume (90 days)

Price summary

52-Week low

1.98

52-Week high

3.69

52-Week change

37.26%

Beta

0.41

50-Day moving average

2.67

200-Day moving average

2.39

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-38.16%

Operating margin

-14.14%

Operational effectiveness

Return on assets

-14.10%

Return on equity

-50.25%

Income statement

Revenue (ttm)

0.67

Revenue per share (ttm)

0.67

Quarterly revenue growth (yoy)

Gross profit (ttm)

16.71M

EBITDA

-6,248,388.00

Net income to common (ttm)

-11,758,964.00

Diluted EPS (ttm)

-0.25

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

10.46M

Total cash per share (mrq)

0.23

Total debt (mrq)

3.97M

Total Debt/Equity (mrq)

21.21

Current ratio (mrq)

377.00%

Book value per share (mrq)

0.45

Cash flow

Cash flow statement

-413,418.00

Levered free cash flow (LFCF)

1.05M